Earningsreport

Q1/2025 6/30/2024 EPS 83.460 ZacksConsensus 1.100 ActVsEst 82.360 - Beat

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors